7th Invitation to Manufacturers of Reproductive Health Medicines to Submit an Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP) for Reproductive Health Medicines
UNFPA
7th Invitation to Manufacturers of Reproductive Health Medicines to Submit an Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP) for Reproductive Health Medicines
Request for EOI
Reference:
ERP for Reproductive Health Medicines, UNFPA/DNK/EOI/15/003
Beneficiary countries:
Multiple destinations (see 'Countries' tab below)
Published on:
15-Jan-2015
Deadline on:
15-Mar-2015 17:00 (GMT 1.00)
Description
UNFPA is inviting Expressions of Interest (EOIs) from eligible suppliers in respect to the provision of Reproductive Health Medicines for product evaluation by the WHO Expert Review Panel (ERP).
Isabel Lucas Manzano - manzano@unfpa.org, Tel: +45 45337274
Email:
manzano@unfpa.org
First name:
Isabel
Surname:
Lucas Manzano
Telephone country code:
Denmark (+45)
Telephone number:
45337274
Seloi Mogatle - mogatle@unfpa.org, Tel: +45 45337277
Email:
mogatle@unfpa.org
First name:
Seloi
Surname:
Mogatle
Telephone country code:
Denmark (+45)
Telephone number:
45337277
| Link | Description | |
|---|---|---|
| http://apps.who.int/prequal/info_press/documents/ERP_article.pdf | A rapid quality risk assessment mechanism for assessing needed pharmaceutical products that have not completed a stringent assessment | |
| http://www.unfpa.org/quality-assurance | UNFPA Quality Assurance policy |
51351509
-
Medroxyprogesterone
51351510
-
Megestrol
51351511
-
Megestrol acetate
51351514
-
Progesterone
51351605
-
Estradiol or oestradiol
51351606
-
Dienogest
51351608
-
Estriol
51351609
-
Fulvestrant
51351612
-
Medroxyprogesterone acetate
51351613
-
Mifepristone
51351627
-
Estradiol valerate
51351635
-
Conjugated estrogens/medroxyprogesterone acetate
51351636
-
Estradiol/trimegestone
51351637
-
Estradiol cypionate/medroxyprogesterone acetate
51351804
-
Estrogens conjugated
51351912
-
Ulipristal acetate
51352005
-
Etonogestrel
51352006
-
Levonorgestrel
51352008
-
Norethindrone or norethisterone
51352404
-
Drospirenone/estradiol
51352413
-
Ethinyl estradiol/levonorgestrel
51352414
-
Ethinyl estradiol/norelgestromin
51352422
-
Desogestrel and ethinyl estradiol
51352426
-
Estradiol/norethindrone
51352435
-
Cyproterone/Estradiol + Estradiol
51352436
-
Ethinylestradiol/cyproterone acetate
Please note that on 19 January 2015 a review took place. The review consisted in uploading updated EOI document to recognise change in the name of the department of WHO conducting the ERP process.
Edited on:
19-Jan-2015 10:25
Edited by:
manzano@unfpa.org